{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:49Z","timestamp":1790286949148,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05709-y","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T09:02:40Z","timestamp":1725440560000},"page":"3141-3149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Digital ischemia: a rare immune-related adverse event of immune checkpoint inhibitors\u2014case report and review of the literature"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6325-8649","authenticated-orcid":false,"given":"Melina","family":"Yerolatsite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4345-6215","authenticated-orcid":false,"given":"Nanteznta","family":"Torounidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-9193","authenticated-orcid":false,"given":"Aliki I.","family":"Venetsanopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-2237","authenticated-orcid":false,"given":"George","family":"Zarkavelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-5986","authenticated-orcid":false,"given":"Davide","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-2284","authenticated-orcid":false,"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"5","key":"5709_CR1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.21873\/anticanres.17010","volume":"44","author":"A Charpidou","year":"2024","unstructured":"Charpidou A, Mani M, Kokkotou E, Stournara L, Stathelou L et al (2024) Molecular diagnostics and treatment patterns in metastatic non-small cell lung cancer patients: real world evidence from Greece: LACHESIS study. Anticancer Res 44(5):2063\u20132072","journal-title":"Anticancer Res"},{"issue":"392","key":"5709_CR2","first-page":"1","volume":"13","author":"M Conroy","year":"2022","unstructured":"Conroy M, Naidoo J (2022) Immune-related adverse events and the balancing act of immunotherapy. Nat Commun 13(392):1\u20134","journal-title":"Nat Commun"},{"key":"5709_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1167975","author":"Q Yin","year":"2023","unstructured":"Yin Q, Wu L, Han L, Zheng X, Tong R (2023) Immune-related adverse events of immune checkpoint inhibitors: a review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1167975","journal-title":"Front Immunol"},{"issue":"e006500","key":"5709_CR4","first-page":"1","volume":"11","author":"CC Barron","year":"2023","unstructured":"Barron CC, Stefanova J, Cha Y, Elsolh K, Zereshkian A et al (2023) Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review. J Immunother Cancer 11(e006500):1\u20137","journal-title":"J Immunother Cancer"},{"key":"5709_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/imr.13242","volume":"318","author":"G Reynolds","year":"2023","unstructured":"Reynolds G (2023) Rheumatic complications of checkpoint inhibitors: lessons from autoimmunity. Immunol Rev 318:51\u201360","journal-title":"Immunol Rev"},{"issue":"11","key":"5709_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417","journal-title":"Rheumatol Int"},{"key":"5709_CR7","volume":"8","author":"A Thomas","year":"2022","unstructured":"Thomas A, Jayan A, Chang Y, Svetgoff R, Datar S et al (2022) Pembrolizumab-associated acral necrosis and esophageal necrosis. Curr Probl Cancer: Case Rep 8:100193","journal-title":"Curr Probl Cancer: Case Rep"},{"issue":"10","key":"5709_CR8","first-page":"1","volume":"6","author":"J Kefas","year":"2022","unstructured":"Kefas J, Harwood C, Lewis MJ, Szlosarek P (2022) Small vessel vasculitis and dry gangrene secondary to combined CTLA-4 and PD-1 blockade in malignant mesothelioma. BMC Rheumatol 6(10):1\u20135","journal-title":"BMC Rheumatol"},{"issue":"e233463","key":"5709_CR9","first-page":"1","volume":"13","author":"P O\u2019Connor","year":"2020","unstructured":"O\u2019Connor P, Laury R, Bhadbhade P, Khan Q, Williamson S (2020) Acral vascular syndrome during an immune checkpoint inhibitor. BMJ Case Rep 13(e233463):1\u20136","journal-title":"BMJ Case Rep"},{"key":"5709_CR10","first-page":"1","volume":"2834","author":"N Zenati","year":"2019","unstructured":"Zenati N, Charles J, Templier I, Blaise S (2019) Isch\u00e9mie digitale avec ulc\u00e9ration pulpaire sous ipilimumab\/ Digital ischaemia with fingertip ulcers during ipilimumab therapy. Rev Mal Respir Actual 2834:1\u20135","journal-title":"Rev Mal Respir Actual"},{"issue":"449","key":"5709_CR11","first-page":"1","volume":"19","author":"K Khaddour","year":"2019","unstructured":"Khaddour K, Singh V, Shayuk M (2019) Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review. BMC Cancer 19(449):1\u20136","journal-title":"BMC Cancer"},{"issue":"5","key":"5709_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2217\/imt-2018-0082","volume":"11","author":"F Franco","year":"2019","unstructured":"Franco F, Mendez M, Gutierrez L, Sanz J, Calvo V et al (2019) Nivolumab-associated digital small-vessel vasculitis in a patient with an advanced renal cell carcinoma. Immunotherapy 11(5):379\u2013384","journal-title":"Immunotherapy"},{"issue":"12","key":"5709_CR13","first-page":"1","volume":"6","author":"A Padda","year":"2018","unstructured":"Padda A, Schiopu E, Sovich J, Ma V, Alva A et al (2018) Ipilimumab induced digital vasculitis. J Immunother Cancer 6(12):1\u20135","journal-title":"J Immunother Cancer"},{"issue":"120","key":"5709_CR14","first-page":"1","volume":"6","author":"T Comont","year":"2018","unstructured":"Comont T, Sibaud V, Mourey L, Cougoul P, Beyne-Rauzy O (2018) Immune checkpoint inhibitor-related acral vasculitis. J Immunother Cancer 6(120):1\u20133","journal-title":"J Immunother Cancer"},{"issue":"327","key":"5709_CR15","first-page":"1","volume":"17","author":"T Gambichler","year":"2017","unstructured":"Gambichler T, Strutzmann S, Tannapfel A, Susok L (2017) Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade. BMC Cancer 17(327):1\u20135","journal-title":"BMC Cancer"},{"key":"5709_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210820","author":"S Le Burel","year":"2017","unstructured":"Le Burel S, Champiat S, Routier E, Aspeslagh S, Albiges L et al (2017) Onset of connective tissue disease following anti-PD1\/PD-L1 cancer immunotherapy. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210820","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5709_CR17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1136\/annrheumdis-2017-211560","volume":"76","author":"ST Kim","year":"2017","unstructured":"Kim ST, Tayar J, Trinh VA, Suarez-Almazor M, Garcia S et al (2017) Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series. Ann Rheum Dis 76(12):2061","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5709_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40425-019-0711-0","volume":"7","author":"YR Badran","year":"2019","unstructured":"Badran YR, Cohen JV, Brastianos PK, Parikh AR, Hong TS et al (2019) Concurrent therapy with immune checkpoint inhibitors and TNF\u03b1blockade in patients with gastrointestinal immune-related adverse events. J Immunother Cancer 7(1):226","journal-title":"J Immunother Cancer"},{"issue":"5","key":"5709_CR19","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s10620-009-0839-8","volume":"55","author":"JD Lord","year":"2010","unstructured":"Lord JD, Hackman RC, Moklebust A, Thompson JA, Higano CS et al (2010) Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells. Dig Dis Sci 55(5):1396","journal-title":"Dig Dis Sci"},{"issue":"5","key":"5709_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13075-014-0469-1","volume":"16","author":"S Ceeraz","year":"2014","unstructured":"Ceeraz S, Nowak EC, Burns CM, Noelle RJ (2014) Immune checkpoint receptors in regulating immune reactivity in rheumatic disease. Arthritis Res Ther 16(5):469","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"5709_CR21","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/art.27500","volume":"62","author":"AP Raptopoulou","year":"2010","unstructured":"Raptopoulou AP, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I et al (2010) The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum 62(7):1870\u20131880","journal-title":"Arthritis Rheum"},{"key":"5709_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13075-015-0859-z","volume":"17","author":"C Liu","year":"2015","unstructured":"Liu C, Jiang J, Gao L, Wang X, Hu X et al (2015) Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways. Arthritis Res Ther 17:340","journal-title":"Arthritis Res Ther"},{"issue":"126","key":"5709_CR23","first-page":"222","volume":"38","author":"E Pontarini","year":"2020","unstructured":"Pontarini E, Verstappen GM, Grigoriadou S, Kroese FGM, Bootsma H et al (2020) Blocking T cell co-stimulation in primary Sj\u00f6gren\u2019s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers. Clin Exp Rheumatol 38(126):222\u2013227","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"5709_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.reuma.2022.05.001","volume":"19","author":"A Moneim","year":"2023","unstructured":"Moneim A, Hosny MM, Omard HH, Abdelnabya MM, Fouad MM et al (2023) Relative CTLA-4, PTPN-22, and interleukin 37 mRNA expressions in patients with lupus nephritis. Reumatol Cl\u00edn 19(4):180\u2013187","journal-title":"Reumatol Cl\u00edn"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05709-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:04:45Z","timestamp":1733328285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5709"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05709-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"9 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of General University Hospital of Ioannina (protocol code 649\/17\u201307-2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}